Prognostic implications of HER2 changes after neoadjuvant chemotherapy in patients with HER2-zero and HER2-low breast cancer-Reference-Cited by-同舟云学术

Prognostic implications of HER2 changes after neoadjuvant chemotherapy in patients with HER2-zero and HER2-low breast cancer

Published:2023-09 Issue: Volume:191 Page:112956
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Kang Sora^ORCID,Lee So Heun,Lee Hee Jin^ORCID,Jeong Hyehyun^ORCID,Jeong Jae Ho,Kim Jeong Eun^ORCID,Ahn Jin-Hee,Jung Kyung Hae^ORCID,Gong Gyungyub,Kim Hak Hee,Lee Saebyeol,Lee Jongwon,Kim Sung-Bae^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference29 articles.

1. Breast cancer;Harbeck;Nat Rev Dis Primers,2019

2. Trastuzumab deruxtecan in previously treated HER2-low advanced breast cancer;Modi;N Engl J Med,2022

3. HER2-low breast cancer: pathological and clinical landscape;Tarantino;J Clin Oncol,2020

4. Clinical, pathological, and PAM50 gene expression features of HER2-low breast cancer;Schettini;NPJ Breast Cancer,2021

5. HER2-Low breast cancer: molecular characteristics and prognosis;Agostinetto;Cancers,2021

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling Neoadjuvant Therapy: Insights and Outlooks for HER2-Positive Early Breast Cancer;Current Treatment Options in Oncology;2024-08-17

2. HER2-Low Breast Cancer: Now and in the Future;Cancer Research and Treatment;2024-07-15

3. Unraveling the clinicopathological and molecular changes induced by neoadjuvant chemotherapy and endocrine therapy in hormone receptor-positive/HER2-low and HER2-0 breast cancer;ESMO Open;2024-07

4. A population-based study on trajectories of HER2 status during neoadjuvant chemotherapy for early breast cancer and metastatic progression;British Journal of Cancer;2024-06-28

5. HER2-low breast cancer and response to neoadjuvant chemotherapy: a population-based cohort study;Pathology;2024-04